A phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma of the bladder after bacillus calmette-guerin failure
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 22 May 2008
At a glance
- Drugs CG 0070 (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 22 May 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 22 May 2008 Interim results have been presented at the 103rd Annual Meeting of the American Urological Association, held in Orlando, Florida USA.
- 17 Jan 2008 The expected completion date for this trial is now 1 Sep 2010.